Log In
BCIQ
Print this Print this
 

LNK-754

  Manage Alerts
Collapse Summary General Information
Company Link Medicine Corp.
DescriptionOral farnesyl transferase inhibitor
Molecular Target Farnesyl transferase
Mechanism of ActionFarnesyl transferase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat mild Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today